Showing results (121-130 of 151) with videos related to
Sort By:
Pageof 16
Cancer|February 21, 2018
Impact of the affordability of novel agents in patients with multiple myeloma: Real-world data of current clinical practice in MexicoLuz Tarín-Arzaga, Daniela Arredondo-Campos, Victor Martínez-Pacheco, et al.Haematologica|December 3, 2011
Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host diseaseCesar Homero Gutiérrez-Aguirre, Olga Graciela Cantú-Rodríguez, Omar David Borjas-Almaguer, et al.Annals of Hematology|August 26, 2009
Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemiaDavid Gómez-Almaguer, José Carlos Jaime-Pérez, Verónica Garza-Rodríguez, et al.JCO Global Oncology|February 20, 2026
Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALLJulia Esther Colunga Pedraza, Andrés Gómez-De León, Perla Rocío Colunga Pedraza, et al.Journal of Clinical Apheresis|January 6, 2015
Effective collection of peripheral blood stem cells in children weighing 20 kilogram or less in a single large-volume apheresis procedureRosario Salazar-Riojas, José Alberto García-Lozano, Mayra Valdés-Galván, et al.Hematology, Transfusion and Cell Therapy|September 26, 2022
Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantationPerla R Colunga-Pedraza, Mariela Irabien-Zuñiga, Carlos Saúl Rodriguez-Roque, et al.European Journal of Haematology|March 9, 2013
High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopeniaDavid Gómez-Almaguer, Luz Tarín-Arzaga, Brizio Moreno-Jaime, et al.Journal of Clinical Apheresis|May 18, 2013
Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with clinically advanced diseaseDavid Gómez-Almaguer, Álvaro Gómez-Peña, José Carlos Jaime-Pérez, et al.Hematology (Amsterdam, Netherlands)|June 6, 2012
CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic valueManuel Solano-Genesta, Luz Tarín-Arzaga, Ileana Velasco-Ruiz, et al.Hematology (Amsterdam, Netherlands)|February 25, 2016
More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpuraAlberto Vazquez-Mellado, Myrna Pequeño-Luévano, Olga Graciela Cantu-Rodriguez, et al.Pageof 16